The bacterial sliding clamp (SC), also known as the DNA polymerase III β subunit, is an emerging antibacterial target that plays a central role in DNA replication, serving as a protein-protein interaction hub with a common binding pocket to recognize linear motifs in the partner proteins. Here, fragment-based screening using X-ray crystallography produced four hits bound in the linear-motif-binding pocket of the Escherichia coli SC. Compounds structurally related to the hits were identified that inhibited the E. coli SC and SC-mediated DNA replication in vitro. A tetrahydrocarbazole derivative emerged as a promising lead whose methyl and ethyl ester prodrug forms showed minimum inhibitory concentrations in the range of 21-43 μg/ mL against representative Gram-negative and Gram-positive bacteria species. The work demonstrates the utility of a fragment-based approach for identifying bacterial sliding clamp inhibitors as lead compounds with broad-spectrum antibacterial activity. 
INTRODUCTION
The emergence of antibiotic-resistant bacteria has presented a great challenge to humanity 1 with new classes of antibiotics acting on novel targets being urgently needed. [2] [3] [4] The bacterial sliding clamp (SC), also known as the DNA polymerase III (Pol III) β subunit, is a torus-shaped homodimeric protein 5 that is conserved across bacterial species. [6] [7] [8] The SC serves as a protein-protein interaction (PPI) hub during bacterial DNA replication and repair, 9, 10 surrounding double-stranded DNA and subsequently recruiting a diverse range of protein binding partners, including the δ and α subunits of DNA Pol III, DNA Pols I, II, IV, V and MutS. 5, 9 The pivotal role it plays in bacterial DNA replication and repair, its conserved structure across bacterial species [6] [7] [8] and its structural divergence from the equivalent human protein (proliferating cell nuclear antigen, PCNA) 9, 11 make the SC a highly attractive target for producing new antibiotics acting via a novel mechanism.
Proteins that interact with the SC recognise a surface binding pocket that consists of two subsites (I and II), 6, 12, 13 with one pocket located on each of the SC monomers ( Figure 1 ). These protein binding partners interact with the SC using linear motifs (LMs) located on their surfaces. 5, 13, 14 LMs are short (4-10 residue), intrinsically disordered sequences most often found at the termini of proteins but sometimes in loop regions. [15] [16] [17] Binding of LMs to rigid protein domains represents a distinct category of protein-protein interactions (PPIs) that generally display weak affinities (K d ~ 1-100 µM). [18] [19] [20] [21] [22] [23] PPIs are attractive drug targets, but the development of small-molecule inhibitors is considered challenging due in part to the shape and large surface areas of such sites. 24 Nevertheless, an increasing number of inhibitors of PPIs are being reported, with recent examples including inhibitors of clathrin, 25 the polo-box domain of polo-like kinase 1 26 and 14-3-3 protein 27 .
A consensus LM sequence QLx 1 Lx 2 F/L (S/D preferred at x 1 ; x 2 may be absent) has been identified that interacts with the SC LM-binding pocket, and isolated peptides based on this sequence have been shown to bind the SC ( Figure 1A ) with affinities similar to their parent proteins [28] [29] [30] and, conversely, when LMs are removed from the parent proteins, they lose all SC affinity. 13, 31 Our recent work proposed a mechanism of sequential binding of LMs to the E. coli SC and highlighting the role of subsite I as the "anchor site" for LM recognition. 30 Two classes of small molecules have previously been reported that bind to subsite I (K i >10 µM), but no antibacterial activities were provided for these compounds. In this work, X-ray crystallography was used as a primary screen to identify fragment hits against the E. coli SC. Binding poses adopted by these hits were used in combination with chemo-informatics to guide subsequent inhibitor design, with several promising compounds being identified that bind to the SC, disrupt LM-SC interactions and inhibit SC-dependent DNA replication in vitro. Anti-bacterial activity was demonstrated for a lead inhibitor against two Gram negative and two
Gram positive bacterial species.
RESULTS

Fragment-Based Screening Using X-Ray Crystallography. A total of 352 fragment compounds from the First Pass
Screen (Zenobia Fragment Libraries) were soaked into E. coli SC crystals as 4-in-1 cocktails and screened using X-ray crystallography. Four fragment hits showing good electron density: 3,4-difluorobenzamide 1, 5-chloroisatin 2, 6-nitrobenzopyrazole 3 and 5-nitroindole 4, were found to bind in subsite I of the binding pocket on Chain A of the SC dimer (complexes denoted as SC 1 , SC 2 , SC 3 and SC 4 , respectively, in Figure 2 ; crystallographic data are in Table S1 , Supporting Information). No significant changes in the SC main-chain structure were observed upon fragment binding. Several other fragments were identified that bind in subsite I but they showed only weak electron density and were not investigated further.
An additional six fragments were identified that bound only in the binding pocket of chain B, where they were stabilized by a symmetry-related protein molecule. These were considered to be crystallographic artefacts and were not pursued. The four fragment hits bound in the deep region of subsite I forming van der Waals' interactions with the hydrophobic side chains of V360, V247, L177 and M362 ( Figure 2 ). The shallow region of subsite I, comprising residues T172, P242 and L155, remained vacant ( Figures 1B and 2 ). Each fragment positioned an aromatic ring in the narrow groove of subsite I with the fluoro and chloro substituents of 1 and 2 being buried in the deep hydrophobic region (Figure 2A ,B). Binding of both 1 and 2 caused rotation of the side chain of S346 relative to the apo-SC structure. Fragments 3 and 4 bound in a similar manner to 1 and 2 placing their NO 2 groups in the positions occupied by the halogen atoms of 1 and 2 ( Figure 2C ,D). The NO 2 groups appeared to accept H-bonds from the side-chain of S346, allowing this residue to retain the same conformation it adopts in the apo-SC structure.
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A fluorescence polarization (FP)-based competition assay was used to quantify inhibition of a LM-SC interaction by the four fragment hits. 30 In this assay, a fluorescently labeled SC-binding tracer peptide based on a LM derived from the consensus-binding motif (5-carboxyfluorescein-QLDLF, K d = 70 nM) 12, 32, 33 was used as the competitive probe ligand.
Inhibition of tracer binding to the E. coli SC was plotted against inhibitor concentrations and IC 50 values were calculated and transformed into inhibition constants (K i ) using the Kenakin correction for ligand depletion. 34 None of the four hits 1-4
showed any significant inhibition of probe binding below 1 mM under the assay conditions (data not shown).
Identification of Fragments That Fully Occupy Subsite I.
Following identification of fragment hits 1-4, we sought to improve binding affinity by identifying fragments that could more completely occupy subsite I, including the shallow region.
It was noted that the fluoroaryl ring found in 1 was also present in the previously reported biphenyl inhibitor 28 , triggering further investigations with compound 5,a readily available analogue containing the fluorobiphenyl moiety (Table 1) . A K i of 280 µM was measured for 5 using the FP assay 30 (Table 1) and its X-ray co-crystal structure was solved in complex with the SC (denoted SC 5 ). Compound 5 was found to fully occupy subsite I ( Figure 3A ; crystallographic data in Table S2 , Supporting Information), with its fluoroaryl ring adopting a similar binding pose to that of 1. The side-chain of M362 was observed to rotate toward subsite II, possibly due to steric crowding. The second phenyl ring of 5 occupied the shallow region of subsite I, with its carboxylate group involved in a salt bridge and/or H-bonds with the side chains of R152 and Y154. Both of these side chains move slightly toward the carboxylate of 5 relative to their positions in the apo-structure.
The ZINC library 35 was subsequently searched for compounds displaying structural similarity to fragments 1-5. Selected molecules were subjected to a docking-based screen using UCSF DOCK6.5 36 and candidates were purchased for screening using the FP assay. Initial efforts failed to yield hits with K i < 1 mM but it was noted during the work that 5-chlorocarbazoles appeared promising. Further searches of the ZINC library 35 identified several 5-chlorocarbazoles including 6, which showed a K i of 199 µM (Table 1 and Table S3 , Supporting Information). The X-ray co-crystal structure of 6 was obtained, but the compound, although clearly binding in subsite I, showed only weak electron density (data not shown).
The slight curvature at the base of subsite I (due to P242) appeared likely to impair binding of rigid/planar compounds like 6 and it was postulated that ligands with increased flexibility might better complement the curvature. Searches of the ZINC library 35 (Table S3 , Supporting Information) identified tetrahydrocarbazoles 7 and 8, which were found to have K i values of 216 and 64 µM, respectively (Table 1) . Compounds 9 and 10, the methyl and ethyl esters of 8, displayed significantly weaker binding, highlighting the importance of the acid group. Eighteen additional tetrahydrocarbazoles were synthesized and evaluated using the FP assay but all showed poor SC binding affinities (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , Table S3 and Scheme S1, Supporting Information).
The X-ray co-crystal structures of 7 and 8 in complex with the E. coli SC were solved (denoted as SC 7 and SC 8 in Figure   3B ,C; crystallographic data in Table S2 , Supporting Information). Compounds 7 and (R)-8 were both found to completely occupy subsite I with their tetrahydrocarbazole rings nestled against P242. Binding of 7 preserved the position of all residues in subsite I and had no effect on the overall protein structure. The carboxylate group of 7 made two H-bonds to the backbone carbonyl oxygen atom of V247 and the hydroxyl group of S346. Interestingly, while the commercially obtained carboxy-5-chlorotetrahydrocarbazole 8 was racemic only the (R)-enantiomer appeared in the electron density map ( Figure 3C ). The binding of (R)-8 caused conformation changes in the M362 and S346 side chains relative to the apo-structure and buried the 5-chloro group in the hydrophobic deep region of subsite I. The carboxyl group of 8 appeared to interact with the guanidinium group of R152, which may explain the preference for binding of the (R)-enantiomer in the crystal.
Ligand efficiency (LE) and ligand lipophilicity efficiency (LLE AT ) 37 were calculated (Supporting Information) to assess the suitability of these fragments for further medicinal chemistry optimization ( Figure S1 (Supporting Information). It is noteworthy that when superimposed, the aryl ring systems of all three compounds are approximately coplanar and project their halogens into the deep region of subsite I ( Figure 1B) . While all three compounds show lowmicromolar affinity, RU7 and the biphenyloxime ether derivative project large moieties towards bulk solvent that appear to contribute few (if any) binding interactions. In the case of RU7, the thiocarbonyl and carboxymethyl moieties are oriented toward solvent while the biphenyloxime ether derivative projects its substituted cyclohexyl moiety toward the solvent.
Compound (R)-8, on the other hand, projects no groups out into the solvent and better complements the geometry of subsite I, thus suggesting it is a more suitable lead for optimization studies. The SC is loaded onto the primed DNA by the clamp loader complex and the α subunit (bound to the SC) catalyzes extension of the primer through incorporation of dNTPs using ssDNA as a template. A schematic illustration of this assay is shown in the Supporting Information ( Figure S3 ).
With this assay system, binding of the DNA Pol III δ and α subunits to the SC is essential for replication, meaning impaired SC binding due to the presence of inhibitors will hinder DNA synthesis, as shown by the presence of ssDNA templates and incomplete dsDNA products. A complete dsDNA product is formed when the whole of the ssDNA circle is replicated (see Figure S4 , Supporting Information for control experiment). Compounds 5, 6 and 7 were found to inhibit replication at 500 or 1000 µM ( Figure 4A -C), while compound 8 produced complete inhibition at 250 µM ( Figure 4D ), consistent with its higher SC affinity (Table 1 ). The antibacterial effects of compounds 5, 7-10 were carried out against two representative Gram-negative (E. coli and A.
baylyi) and two Gram-positive (B. subtilis and S. aureus) species. The background-corrected optical density was measured after 24 hours of bacterial growth (Table S4 , Supporting Information). The minimum inhibitory concentrations (MICs), defined as the background-corrected optical densities of less than 0.1, are shown in Table 2 . Compounds 5 and 7 showed only slight antibacterial activity (MICs 540 to 1246 µg/mL), consistent with their modest E. coli SC-binding affinities (Table 1) .
Their carboxylic acid groups may have reduced membrane penetration. The MIC of 8 (39-78 µg/mL) was lower than 5 and 7 against all four species, consistent with its higher SC affinity (Table 1) . Compounds 9 and 10 were considered as possible prodrug forms of 8 (i.e., methyl and ethyl esters, respectively) that might show improved membrane penetration properties.
Esters 9 and 10 displayed increased antibacterial activity relative to 8 (MICs 21-43 µg/mL) despite having lower affinities for the SC (Table 1) , consistent with their acting as membrane permeable prodrugs. 
DISCUSSION
PPIs are often considered difficult targets to inhibit with small molecules. 45 Nevertheless, several PPI inhibitors have been successfully developed. 46 Studies indicate that PPIs rely on so-called "hotspots" for most of the interaction energy and, accordingly, these are usually the most productive sites for inhibitor design. 24 We previously identified subsite I as the "anchor site" of consensus peptide binding to the E. coli SC, indicating that this site acts as the SC "hotspot". 30 We also
showed that the affinity of peptide LMs for the E. coli SC arises from residues occupying both subsites I and II, 30 suggesting that the potential of these individual subsites as drug targets is probably limited. The close proximity of the two subsites, however, suggests that fragment-based approaches are highly suited to identifying inhibitors of this target.
Fragment screening in the current work using X-ray crystallography initially identified four hits, but these proved to be weak binders (K i >1 mM). The high sensitivity of X-ray crystallography and its ability to identify weak binders in fragmentbased screening efforts has previously been noted.
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All four hits were found to bind in subsite I, i.e., the LM "anchor site". against representative bacteria, these effects were improved upon masking the carboxylic acid as methyl and ethyl ester prodrugs (compounds 9 and 10, MICs 21-43 µg/mL). In this study the X-ray crystallography screening, and FP and in vitro DNA replication assays were all carried out using the SC from E. coli, yet similar antibacterial potencies were observed with compounds 9 and 10 against E. coli, A. baylyi, B. subtilis and S. aureus. This finding is consistent with the high conservation of SC structure across bacterial species 6 and suggests that the E. coli SC serves as an excellent model system for identifying SC inhibitors that could potentially be developed into broad-spectrum antibiotics.
Current work in our laboratories aims to improve the SC affinities of the tetrahydrocarbazoles by targeting both subsite I and II. Our previous work suggested that residues of peptide ligands occupying subsite II contribute significantly to the binding affinity and that binding at subsite II is subsequent to binding at subsite I (the "anchor site"). 30 A conformational change in the side chain of M362 was proposed to act as a gate in the channel region connecting subsite I and II. 30 A similar conformational change in M362 was observed with the binding of (R)-8 in subsite I ( Figure 3C ). Therefore the synthesis of tetrahydrocarbazole derivatives substituted at the nitrogen atom may expand the inhibitor-binding area beyond subsite I, into the channel region and subsite II.
Materials and Methods
Compounds. Fragment compounds (including 1-4) were purchased from Zenobia Therapeutics (First-Pass Screen library).
Compounds 5-10 and 6a-c were purchased from Sigma-Aldrich, Labotest, Enamine or Vitas-M Laboratory. Purchased compounds were ≥ 95% pure as confirmed by proton NMR and/or LC-MS. Compounds 11-29 (Table S3 , Supporting Information) were synthesized in house (Scheme S1, Supporting Information).
Protein Over-expression and Purification. Expression and purification of the E. coli SC, Pol III α subunit, SSB and the clamp loader complex (γ 3 δδ') were as described previously.
29, 38, 39, 48
Crystallization and X-Ray Data Collection. Crystals of the E. coli SC were grown at 285 K by the hanging-drop vapor diffusion method. The drop was composed of 1 µL of sliding clamp (53 mg/mL) mixed with the same volume of reservoir solution of 100 mM MES pH 6.5, 100-150 mM CaCl 2 and 25-30% (v/v) PEG400. The reservoir volume was 1 mL. SC crystal were moved to a CaCl 2 -free reservoir and ligands were soaked into the crystal at 2-5 mM with < 10% DMSO.
Fragment compounds were mixed as 4-in-1 cocktails as suggested by the supplier and soaked into crystals with each fragment at 5 mM. All crystals were mounted using MiTeGen™ loops on pins with magnetic caps. For in-house data collection crystals were flash-frozen at 100 K using an Oxford Cryo-stream. Diffraction data were collected using a MAR345
desktop beamline using CuKα X-rays from a Rigaku 007HF rotating anode generator with Varimax™ optics. For synchrotron data collection, the SSRL Automated Mounting system (SAM) was used. Mounted crystals were flash-frozen in liquid nitrogen and diffraction data were collected at the Australian Synchrotron, Beamline MX1 (X-ray wavelength 0.95 Å) Experiments followed the CLSI broth microdilution method. 54 Briefly, strains were grown overnight and diluted to 5 x 10 4 CFU/mL with cation-adjusted Mueller Hinton II broth and used as inoculated medium for bacterial growth. Serial 2-fold dilution of candidate compounds (pre-dissolved in DMSO at 100 mM) or antibiotics were carried out in sterile 96-well plates.
Controls consisted of the growth medium only (blank controls) or inoculated medium with 5% DMSO or DMSO diluted as for the test compounds (negative controls), and inoculated medium with antibiotics (positive controls). Optical density values of each inoculated culture were measured at wavelength 595 nM as the background using a plate reader (Tecan Infinite M200 Pro). The plates were incubated for 24 h at 37°C and then the optical density values of the bacterial culture were measured again. MICs were defined as the lowest compound concentration with background-subtracted optical density < 0.1.
DNA replication assay.
Each assay contained 20 mM Tris-HCl pH 7.6, 10 mM MgCl 2 , 0.8 mM ATP, 8.4 mM dithiothreitol, 0.6 mM of each dNTP, 211 nM Pol III α subunit, 700 nM SSB (as tetramers), 210 nM Pol III β subunit (as dimers), 42 nM γ 3 δδ' clamp loader complex, 120 mM NaCl and 3 nM RNA primed M13 ssDNA template, in a volume of 6.8
µL. Compounds were dissolved in DMSO and diluted in series 2-fold (in 50% v/v DMSO) before being added (0.5 µL) to the assay mixture at 0°C. The final DMSO concentration was 3.4% (v/v) in all assays. The assay mixtures were treated at 30°C
for 60 min before being quenched by the addition of EDTA to 150 mM and SDS to 1% (w/v). The DNA products were separated by 0.7% agarose gel electrophoresis in TAE buffer (80 mM Tris, 40 mM acetic acid, and 4 mM EDTA) and then stained with 10,000-fold diluted SYBR Gold (Invitrogen) for 60 min. The DNA products were visualized using a UV transilluminator.
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Crystallographic data, additional chemical and biochemical data and figures, detailed materials and methods. This material is available free of charge via the Internet at http://pubs.acs.org.
Accession Codes
The atomic coordinates and structure factors for SC Values for data in the highest resolution shell are given in parentheses. Diffraction data for SC 5 were collected at Beamline MX1, Australian Synchrotron, at a wavelength of 0.95 Å. Diffraction data for SC 7 and SC 8 were collected using an in-house X-ray generator (University of Wollongong) at a wavelength of 1.5418 Å. Diffraction data were processed with MOSFLM and SCALA. *Ligands refer to the compounds bound to Chain A. n/a n/a n/a n/a 14 Cl CO2H H H cyclohexyl > 1000 n/a n/a n/a n/a 15 H Cl H H 3-CO2Et cyclohexyl > 1000 n/a n/a n/a n/a 16 H Cl H H 3-CO2H cyclohexyl > 1000 n/a n/a n/a n/a 17 H Cl H H 3-CO2Me cyclohexyl > 1000 n/a n/a n/a n/a 18 H Cl H H cyclopentyl > 1000 n/a n/a n/a n/a 19 H Cl H H 3-piperidinyl > 1000 n/a n/a n/a n/a 20 H Cl H H cycloheptyl > 1000 n/a n/a n/a n/a 21 Cl H H H 1-CO2Me cyclohexyl > 1000 n/a n/a n/a n/a 22 H H H Cl cyclohexyl > 1000 n/a n/a n/a n/a 23 H H H Cl 3-CO2Et cyclohexyl > 1000 n/a n/a n/a n/a 24 H H H Cl 3-CO2H cyclohexyl > 1000 n/a n/a n/a n/a 25 H Cl OH H cyclohexyl > 1000 n/a n/a n/a n/a 26 CO2H Cl H H 2-CO2H cyclohexyl > 1000 n/a n/a n/a n/a 27 CO2H Cl H H cyclopentyl > 1000 n/a n/a n/a n/a 28 CO2H Cl H H cycloheptly > 1000 n/a n/a n/a n/a 29 H Cl CO2Me H cyclohexyl > 1000 n/a n/a n/a n/a n/a: not applicable Figure S1 . Inhibition of binding of a fluorescently labelled tracer peptide (5FAM-QLDLF) to the E. coli SC. Data are standardized and shown as inhibition (%, decreased polarization divided by background subtracted total polarization). Error bars represent standard deviation (n=2).
Scheme S1. Synthesis of substituted tetrahydrocarbazoles 11-29. Reagents: (a) AcOH or EtOH and HCl (cat)), ketone, reflux, 3-64%; (b) i) AcOH, ketone, reflux, ii) MeOH, H 2 SO 4 (cat.) reflux, 18%; (c) i) NaOH, EtOH, rt., ii) MeOH, H 2 SO 4 (cat.) reflux, 44%; (d) NaOH, EtOH, rt, 31-47%; (e) MeOH, H 2 SO 4 (cat.) reflux, 65%. 
Supplementary Methods
Molecular Docking and Chemo-Informatics. Fragment scaffolds were used for similarity and/ or substructure searches in the UCSF ZINC library. 3 A number of larger scaffolds were used for substructure search of commercially available compounds for molecular docking using UCSF DOCK 6.5. 4 The receptor was prepared by removing all crystallographic water molecules from the sidling clamp except for a structurally conserved water molecule near residue M362.
Residues greater than 15 Å away from the binding pocket were deleted. Hydrogen atoms were added and partial charges were assigned. Ligands were prepared using UCSF Chimera or downloaded from UCSF ZINC library. Spheres for ligand orientations were generated using the identified fragment binders. A grid map for scoring was generated encompassing residues within 15 Å of the spheres. Docking was carried out using Grid score as the primary score and GB/SA Hawkins score as a secondary scoring method. The top 50 poses were clustered and the top 10 cluster heads assessed using the secondary scoring method. Additionally, Amber scoring 5 was performed with 100 steps of minimization, 3000 md cycles and another 100 minimization steps, each step corresponded to 2 fs. In all cases ligand flexibility was allowed and the receptor kept rigid. Selected molecules were acquired for testing.
Calculation of LogD values at pH 7.2 was performed using Accord for Excel 6.2 (Accelrys).
The equations used to determine LE and LLE AT followed the published methods 6 and are detailed below: 
6-chloro-2,3,4,9-tetrahydrocarbazole-2,5-dicarboxylic acid (26)
General Fischer indole procedure with 2-chloro-5-hydrazinobenzoic acid hydrochloride (32; 196.5 mg, 0.88 mmol) and 3-oxocyclohexanecarboxylic acid (117.4 mg, 0.83 mmol) in glacial acetic acid (2 mL) produced a mixture of two isomers. The desired isomer was separated by first methylating the mixture (general esterification procedure), followed by FCC on silica gel (40:60:0.5 EtOAc/petrol/acetic acid) to give the mono-methylated 6-chloro-2,3,4,9-tetrahydrocarbazole-2,5-dicarboxylic acid (48.5 mg), which was demethylated (general deesterification procedure) to give 26 (15.6 mg, 10% yield) as a pale yellow powder, mp 222 -224 °C. 1 
